These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31927313)
1. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor. Salem MA; Ragab A; Askar AA; El-Khalafawy A; Makhlouf AH Eur J Med Chem; 2020 Feb; 188():111977. PubMed ID: 31927313 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives. Ammar YA; Farag AA; Ali AM; Ragab A; Askar AA; Elsisi DM; Belal A Bioorg Chem; 2020 Nov; 104():104164. PubMed ID: 32896807 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies. Ammar YA; Farag AA; Ali AM; Hessein SA; Askar AA; Fayed EA; Elsisi DM; Ragab A Bioorg Chem; 2020 Jun; 99():103841. PubMed ID: 32325335 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives. El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects. Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841 [TBL] [Abstract][Full Text] [Related]
6. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469 [TBL] [Abstract][Full Text] [Related]
7. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition. Ismail MMF; Abdulwahab HG; Nossier ES; El Menofy NG; Abdelkhalek BA Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260 [TBL] [Abstract][Full Text] [Related]
9. Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies. Ghannam IAY; Abd El-Meguid EA; Ali IH; Sheir DH; El Kerdawy AM Bioorg Chem; 2019 Dec; 93():103373. PubMed ID: 31698294 [TBL] [Abstract][Full Text] [Related]
10. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV. Metwally NH; Abdallah SO; Mohsen MMA Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481 [TBL] [Abstract][Full Text] [Related]
11. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase. Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors. Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161 [TBL] [Abstract][Full Text] [Related]
13. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA. Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234 [TBL] [Abstract][Full Text] [Related]
14. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking. Merlani M; Barbakadze V; Amiranashvili L; Gogilashvili L; Poroikov V; Petrou A; Geronikaki A; Ciric A; Glamoclija J; Sokovic M Curr Top Med Chem; 2019; 19(4):292-304. PubMed ID: 30674263 [TBL] [Abstract][Full Text] [Related]
15. Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents. Akhavan M; Foroughifar N; Pasdar H; Bekhradnia A Comb Chem High Throughput Screen; 2019; 22(10):716-727. PubMed ID: 31775594 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 2-oxospiro[indoline-3,4'-[1,3]dithiine]-5'-carbonitrile derivatives by new spiro[indoline-3,4'-[1,3]dithiine]@Cu(NO Moghaddam-Manesh M; Sheikhhosseini E; Ghazanfari D; Akhgar M Bioorg Chem; 2020 May; 98():103751. PubMed ID: 32182517 [TBL] [Abstract][Full Text] [Related]
17. In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents. Desai NC; Vaghani HV; Jethawa AM; Khedkar VM Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100134. PubMed ID: 34169569 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Antimicrobial Evaluation and Molecular Docking of Some Potential 2,6-disubstituted 1H-Benzimidazoles; Non-Classical Antifolates. Harer S; Bhatia M; Kawade V Med Chem; 2019; 15(7):813-832. PubMed ID: 30727904 [TBL] [Abstract][Full Text] [Related]
19. Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities. Hafez HN; El-Gazzar AR; Zaki ME Acta Pharm; 2016 Sep; 66(3):331-51. PubMed ID: 27383884 [TBL] [Abstract][Full Text] [Related]
20. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies. Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]